{
  "trial_id": "NCT01103284",
  "trial_group": "diabetes",
  "generated-by-gpt4-omni-zs": {
    "gen-response": "Age, gender, BMI, fasting basal C-peptide, duration of diabetes diagnosis, presence of significant disease or condition other than type 1 diabetes, use of immunosuppressive or immunomodulating agents, baseline glucagon-stimulated C-peptide AUC.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Fasting C-Peptide",
          "fasting basal C-peptide"
        ]
      ],
      "remaining_reference_features": [
        "Sex: Female",
        "Male",
        "Race/Ethnicity",
        "Daily Insulin Dose"
      ],
      "remaining_candidate_features": [
        "gender",
        "BMI",
        "duration of diabetes diagnosis",
        "presence of significant disease or condition other than type 1 diabetes",
        "use of immunosuppressive or immunomodulating agents",
        "baseline glucagon-stimulated C-peptide AUC."
      ]
    }
  },
  "generated-by-gpt4-omni-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Region of Enrollment, Baseline C-peptide, Body Mass Index, Duration of Diabetes, HbA1c, Insulin Dose,",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Male",
          "Male"
        ],
        [
          "Race/Ethnicity",
          "Race/Ethnicity"
        ],
        [
          "Fasting C-Peptide",
          "Baseline C-peptide"
        ]
      ],
      "remaining_reference_features": [
        "Daily Insulin Dose"
      ],
      "remaining_candidate_features": [
        "Region of Enrollment",
        "Body Mass Index",
        "Duration of Diabetes",
        "HbA1c",
        "Insulin Dose"
      ]
    }
  },
  "generated-by-llama3-70b-in-ts": {
    "gen-response": "##Answer:\nAge, Continuous, Gender, BMI, Fasting Basal C-Peptide, Diabetes Duration,",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Fasting C-Peptide",
          "Fasting Basal C-Peptide"
        ]
      ],
      "remaining_reference_features": [
        "Sex: Female",
        "Male",
        "Race/Ethnicity",
        "Daily Insulin Dose"
      ],
      "remaining_candidate_features": [
        "Gender",
        "BMI",
        "Diabetes Duration"
      ]
    }
  },
  "generated-by-llama3-70b-in-zs": {
    "gen-response": "Age, sex, BMI, fasting basal C-peptide, duration of diabetes, HbA1c, insulin dose, presence of diabetes-related complications, history of immunosuppressive or immunomodulating agents use.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "sex"
        ],
        [
          "Fasting C-Peptide",
          "fasting basal C-peptide"
        ]
      ],
      "remaining_reference_features": [
        "Male",
        "Race/Ethnicity",
        "Daily Insulin Dose"
      ],
      "remaining_candidate_features": [
        "BMI",
        "duration of diabetes",
        "HbA1c",
        "insulin dose",
        "presence of diabetes-related complications",
        "history of immunosuppressive or immunomodulating agents use."
      ]
    }
  }
}